Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)

The Asia Pacific biosurgical agent market was negatively impacted by the COVID-19 pandemic. However, the overall market for biosurgical agent will exhibit modest growth over the forecast period. Growth over the forecast period will be driven by continuing growth of procedures in which in biosurgical agents are used, rising awareness of the clinical benefits of these products on surgical outcomes, and the expanded indications in multiple procedures.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for biosurgical agent market in Asia Pacific from 2019 through 2031.